Key result
Intracellular Ca2+ transients were significantly smaller in ventricular myocytes from patients with severe heart failure (370 nM) compared to non-failing controls (760 nM, p < 0.05).
Why the study?
Does the contribution of sarcoplasmic reticulum Ca2+ release to [Ca2+]i-transients differ between failing and non-failing human myocytes?
Does the contribution of sarcoplasmic reticulum Ca2+ release to [Ca2+]i-transients differ between failing and non-failing human myocytes?
Absolute Event Rate: 370% vs 760%
p-value: p=< 0.05
Changes in the intracellular [Ca2+]i-transient in human heart failure are mainly due to alterations in sarcoplasmic reticulum function rather than L-type Ca2+ current.
Suggests SR Ca2+ handling defects as HF therapeutic target; extends animal data to human myocytes but leaves open clinical translation.
Experiments were performed to determine the relative contributions of direct Ca(2+)-entry through the L-type Ca(2+)-current and of Ca(2+)-release from the sarcoplasmic reticulum (s.r.) to the intracellular [Ca2+]i-transient in isolated human atrial and ventricular myocytes from patients with severe heart failure and from non-failing controls. Cells were isolated from explanted hearts of patients undergoing transplantation because of severe heart failure due to dilated or ischemic cardiomyopathy or from donor hearts which could not be transplanted for technical reasons. Ca(2+)-current densities were -2.1 +/- 0.6 pA/pF in atrial cells, -4.8 +/- 0.5 pA/pF in cells from patients with heart failure and -3.2 +/- 0.5 pA/pF in non-failing controls. [Ca2+]i-transients were significantly smaller in heart failure (370 +/- 33 nM) compared to ventricular cells from non-failing hearts (760 +/- 69 nM, p < 0.05). Atrial myocytes had average [Ca2+]i-transients of 505 +/- 38 nM. After incubation in ryanodine the average [Ca2+]i-transients were not significantly different between different cell types. The results indicate that the relative contribution of Ca(2+) released from the sarcoplasmic reticulum to the [Ca2+]i-transient is significantly smaller in heart failure. The absolute contribution of the L-type Ca(2+)-current to the transient seemed to be comparable in all cell types investigated. As the [Ca2+]i-transient in the presence of ryanodine was comparable in size in all cells, changes of the intracellular [Ca2+]i-transient in heart failure are mainly due to alterations of s.r. function in these cells.
No takes yet. Share an insight, caveat, or question.
Dirk J. Beuckelmann (1998) studied Severe heart failure. Severe heart failure vs. Non-failing controls was evaluated on [Ca2+]i-transients in ventricular cells (p=< 0.05). Intracellular Ca2+ transients were significantly smaller in ventricular myocytes from patients with severe heart failure (370 nM) compared to non-failing controls (760 nM, p < 0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: